[Congressional Record (Bound Edition), Volume 154 (2008), Part 16]
[Extensions of Remarks]
[Pages 21935-21937]
[From the U.S. Government Publishing Office, www.gpo.gov]


                          EARMARK DECLARATION

                                 ______
                                 

                      HON. RODNEY P. FRELINGHUYSEN

                             of new jersey

                    in the house of representatives

                     Wednesday, September 24, 2008

  Mr. FRELINGHUYSEN. Madam Speaker, in compliance with new ``earmark'' 
disclosure procedures adopted by the House Republican Conference, I 
hereby provide the following information regarding requests for funding 
I made of the House Appropriations Committee for inclusion in the 
Department of Defense (DoD) Act for Fiscal Year 2009.
  Specifically, the projects will be included in Title IV, Research, 
Development, Test and Evaluation.
  The FY 2009 Defense Appropriations Act includes:
  $5 million for Remotely Operated Weapons Systems, Weapons and 
Munitions Technology. The entity to receive the funding for this 
project is the United States Army, specifically the Armament Research 
Development and Engineering Center (ARDEC) located at Picatinny 
Arsenal, Picatinny, New Jersey, 07806-5000.
  The funding will be used to accelerate the development and fielding 
of critical Remotely Operated Weapon Systems technologies on DoD 
platforms, increasing soldier survivability while enabling them to 
perform hazardous missions effectively. The use of U.S. taxpayer 
funding is justified because this program will provide near-term and 
long-range benefits to the joint warfighter--Army, Marines, Navy and 
Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $5 million for Advanced Technologies, Energy and Manufacturing 
Science, Weapons and Munitions Technology. The entity to receive the 
funding for this project is the United States Army, specifically the 
Armament Research Development and Engineering Center (ARDEC) located at 
Picatinny Arsenal, Picatinny, New Jersey, 07806-5000.
  Then funding will be used by the Army to meet the urgent need to 
develop and provide a breadth of innovative technology solutions to the 
joint warfighter with a focus on the lethality and survivability 
demands for munitions and armaments. The use of U.S. taxpayer funding 
is justified because this program will provide near-term and long-range 
benefits to the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $4 million for Developmental Mission Integration, Weapons and 
Munitions Technology. The entity to receive the funding for this 
project is the United States Army, specifically the Armament Research 
Development and Engineering Center (ARDEC) located at Picatinny 
Arsenal, Picatinny, New Jersey, 07806-5000.
  The funding will be used to meet the critical need for the ARDEC to 
have the capability and flexibility to ``bridge the gap'' between its 
armaments research activities and Current Force requirements through a 
dedicated effort to mature, update, prototype and ``spin out'' armament 
and munitions technologies needed by the warfighter in the near term (6 
to 12 months). The program will develop, demonstrate and transition 
critical armaments, munitions and logistics technologies needed by Army 
Brigade Combat Teams and Special Forces prior to (i.e. reset periods) 
and during deployment. The use of U.S. taxpayer funding is justified 
because this program will provide near-term and long-range benefits to 
the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $3.2 million for Rapid Prototyping for Special Projects, Weapons and 
Munitions Technology. The entity to receive the funding for this 
project is the United States Army, specifically the Armament Research 
Development and Engineering Center (ARDEC) located at Picatinny 
Arsenal, Picatinny, New Jersey, 07806-5000.
  The funding will be used to capitalize on ARDEC's unique scientific 
and engineering capabilities to develop lethal and non-lethal solutions 
for the joint warfighter in periods of less

[[Page 21936]]

than 6 months. The use of U.S. taxpayer funding is justified because 
this program will provide near-term and long-range benefits to the 
joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $2.4 million for Mitigation of Energetic Single Point Failures, 
Weapons and Munitions Technology. The entity to receive the funding for 
this project is the United States Army, specifically the Armament 
Research Development and Engineering Center (ARDEC) located at 
Picatinny Arsenal, Picatinny, New Jersey, 07806-5000.
  Funding will be used to reduce single point failures which may lead 
to increased costs and jeopardize production of critical munitions 
required by the joint Warfighter. This effort will help increase the 
overall quality of ammunition items for the soldier and reduce the 
potential for disruption of armament production within the industrial 
base and the joint armed services. The use of U.S. taxpayer funding is 
justified because this program will provide near-term and long-range 
benefits to the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $1.6 million for JM&L Joint Munitions and Lethality Mission 
Integration, Munitions Standardization and Effectiveness. The entity to 
receive the funding for this project is the United States Army, 
specifically the Joint Munitions & Lethality Life Cycle Management 
Command (JM&L LCMC) located at Picatinny Arsenal, Picatinny, New 
Jersey, 07806-5000.
  The funding will be used to build a network of strategic 
partnerships, all coordinated with the organizations associated with 
the JM&L LCMC. This program will provide an efficient process and will 
demonstrate how early RDE capabilities and solutions can and should be 
utilized to ``spiral in'' emerging technologies to expedite new system 
development or enhance current systems' performance across all 
services. The use of U.S. taxpayer funding is justified because this 
program will provide near-term and long-range benefits to the joint 
warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $2.4 million for JM&L Warfighter Technology Insertion, Munitions 
Standardization and Effectiveness. The entity to receive the funding 
for this project is the United States Army, specifically the Joint 
Munitions & Lethality Life Cycle Management Command (JM&L LCMC) located 
at Picatinny Arsenal, Picatinny, New Jersey, 07806-5000.
  The funds will be used to develop innovative partnerships with non-
traditional finance or technology companies to expedite rapid solutions 
for the soldier. This new network of innovative suppliers will be 
focused on DoD applications, broadening U.S. suppliers' involvement to 
support the military. The use of U.S. taxpayer funding is justified 
because this program will provide near-term and long-range benefits to 
the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $2.4 million for Rapid Insertion of Developmental Technology, Weapons 
and Munitions Advanced Technology. The entity to receive funding for 
this project is the Stevens Institute of Technology at Castle Point on 
Hudson, Hoboken, NJ 07030, working in partnership with ARDEC at 
Picatinny Arsenal.
  The funding will be used to enhance the Army's ability to accelerate 
the fielding of new systems and technology that are crucial to the 
success of ongoing military operations. Such systems increase the 
protection and survivability of the warfighter as well as enhancing his 
or her effectiveness in the field. The use of U.S. taxpayer funding is 
justified because this program will provide near-term and long-range 
benefits to the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $2.4 million GreenArmaments/Rangesafe, Weapons and Munitions 
Technology. The entity to receive funding for this project is the 
Steven's Institute of Technology at Castle Point on Hudson, Hoboken, NJ 
07030, working in partnership with ARDEC at Picatinny Arsenal.
  The funding will support the Army's Environmental Requirements and 
Technology Assessment (AERTA) to allow the Army to maintain its 
training and test and production facilities at the top operational 
level enabling their continued use to ensure war-fighting readiness. 
The use of U.S. taxpayer funding is justified because this program will 
provide near-term and long-range benefits to the joint warfighter--
Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $3.2 million for Armament Systems Engineering--ASEI2, Weapons and 
Munitions Technology. The entity to receive funding for this project is 
the Steven's Institute of Technology at Castle Point on Hudson, 
Hoboken, NJ 07030.
  This funding will continue a program to provide the Army with the 
tools and methods to support systems architectures, adaptability and 
supportability to allow warfighters to change rapidly with changing 
battlefield conditions. The use of U.S. taxpayer funding is justified 
because this program will provide near-term and long-range benefits to 
the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $3.2 million for Advanced Cluster Energetics, Munitions 
Standardization and Effectiveness. The entity to receive funding for 
this project is the New Jersey Institute of Technology at University 
Heights, Newark, New Jersey 07102-1982, working in partnership with 
ARDEC at Picatinny Arsenal.
  The funding supports a successful program that touches all aspects of 
manufacturing and performance of munitions: 50% manufacturing cost 
reduction; insensitive munitions through encapsulated uniform 
compositions munitions products of superior packing density in the same 
volume leading to greater performance and a reduced logistics tail. ACE 
manufacturing technologies are applicable to conventional explosives, 
insensitive RDX, HMX and PBX-type munitions, nitramine-based 
propellants, and AP-based rocket propellants and bomb fills. The use of 
U.S. taxpayer funding is justified because this program will provide 
near-term and long-range benefits to the joint warfighter--Army, 
Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $1.6 million for Enhanced Jam Resistant Technology for INS/GPS 
Precision, Weapons and Munitions Advanced Technology. The entity to 
receive funding for this project is L3 Communications, 450 Clark Drive, 
Budd Lake, New Jersey 07828.
  The funding will be used to develop technology for missile and rocket 
systems to counter electronic jamming attempts resulting from the 
proliferation of relatively low-cost, sophisticated and powerful GPS 
jammers. This program is important to increase effectiveness of the 
joint warfighter and reduce potential ``collateral damage'' in any zone 
of conflict. The use of U.S. taxpayer funding is justified because this 
program will provide near-term and long-range benefits to the joint 
warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $2.4 million for Lightweight Trauma Module, Medical Materiel/Medical 
Biological Defense. The entity to receive funding for this project is 
Impact Instrumentation at 27 Fairfield Place, West Caldwell, NJ 07006.
  This funding will allow the Army to incorporate newer medical device 
technologies to result in a 60% decrease in mass and cube through the 
integration of five separate, bulky and uncoordinated patient movement 
(PM) devices. The use of U.S. taxpayer funding is justified because 
this program will provide near-term and long-range benefits to the 
joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $1.6 million for Ink-based Desktop Electronic Material Technology, 
University and Industry Research Centers. Funding for this project will 
flow through Picatinny Arsenal in New Jersey to Honeywell Corporation, 
headquartered at 101 Columbia Road, Morristown, New Jersey 07962.
  The funding will allow the Army to develop specialized inks that are 
wholly capable of fabricating electronics that would be printed on 
desktop printers and then incorporated into electronics. Army funding 
for innovative ink-based technology would lower costs and provide the 
Army with significant weight improvements resulting in improved 
mobility and point-of-use printing capability. This innovation would 
replace expensive traditional electronics that are primarily 
manufactured in semi-conductor facilities overseas. The use of U.S. 
taxpayer funding is justified because this program will provide near-
term and long-range benefits

[[Page 21937]]

to the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable.
  $800,000 for Large Area, APVT Materials for Hi-Powered Devices, 
Materials. The entity to receive funding for this project is II-VI 
Corporation, 20 Chapin Road, Suite 1005, Pine Brook, NJ 07058.
  The funding will allow the Air Force to develop Silicon Carbide 
technologies with several key advantages over current technologies, 
including higher power density, better heat dissipation and increased 
bandwidth, thus making it an enabling technology for critical national 
defense applications. The use of U.S. taxpayer funding is justified 
because this program will provide near-term and long-range benefits to 
the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Air Force, the 
requirement of matching funds is not applicable.
  $800,000 for Lightweight Multifunctional Material Technology, Weapons 
and Munitions--SDD. The entity to receive funding for this project is 
Frontier Polymers, 20 Robert Street, Parsippany, New Jersey 07054, 
working with ARDEC at Picatinny Arsenal.
  The funding will allow the Army to improve its ammunition packaging 
and handling systems and enhance the protection of medium and large 
caliber ammunition used throughout the military. The concepts in this 
program (fire/ballistic resistance, reduced weight) can be applied to 
packaging for a wide range of munitions. The use of U.S. taxpayer 
funding is justified because this program will provide near-term and 
long-range benefits to the joint warfighter--Army, Marines, Navy and 
Air Force.
  As this funding will be provided to the United States Army, the 
requirement of matching funds is not applicable
  $1.6 million M-PACT Pure Air Generator, Small Diameter Bomb. The 
entity to receive funding for this project is Marotta Scientific 
Controls, 78 Boonton Avenue, Montville, New Jersey 07045.
  The funding will be used to allow the Air Force to complete 
development of an enhanced high pressure pure air generator (HPPAG) 
system designed to meet the specific operational requirements of the 
Small Diameter Bomb (SDB) program. The use of U.S. taxpayer funding is 
justified because this program will provide near-term and long-range 
benefits to the joint warfighter.
  As this funding will be provided to the United States Air Force, the 
requirement of matching funds is not applicable.
  $800,000 for IM Formulation of Anthrax Therapeutic, Chemical and 
Biological Defense Program. The entity to receive funding for this 
project is Elusys Therapeutics, 25 Riverside Drive, Pine Brook, NJ 
07058.
  This funding will allow the Department of Defense to develop a more 
viable treatment for unvaccinated defense personnel worldwide who have 
suffered from anthrax exposure. The use of U.S. taxpayer funding is 
justified because this program will provide near-term and long-range 
benefits to the joint warfighter--Army, Marines, Navy and Air Force.
  As this funding will be provided to the United States Department of 
Defense, the requirement of matching funds is not applicable.

                          ____________________